Venodilator effects of pranidipine, a 1,4-dihydropyridine Ca2+ channel antagonist, in rats: Comparison with nifedipine and amlodipine

被引:11
|
作者
Hirano, T
Ohura, M
Orito, K
Fujiki, H
Miyakoda, G
Mori, T
机构
[1] 2Nd Tokushima Inst. of New Drug Res., Otsuka Pharmaceutical Co., Ltd., Tokushima 771-01, 463-10 Kagasuno, Kawauchi-cho
关键词
pranidipine (OPC-13340); Ca2+ channel antagonist; circulatory filling pressure; mean; venodilator effect; (rat); DIHYDROPYRIDINE CALCIUM-ANTAGONIST; CONSCIOUS RATS; OPC-13340; PRESSURE; POTENT; CAPACITANCE; BLOCKER; DOGS;
D O I
10.1016/S0014-2999(97)10007-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of pranidipine, a dihydropyridine Ca2+ channel antagonist, on mean circulatory filling pressure, an index of body venous tone, were compared with those of other dihydropyridines (nifedipine and amlodipine) and nitroglycerin in anaesthetized hexamethonium-and norepinephrine-treated rats. In this study, the compounds were used at doses having a equi-hypotensive effect. Intravenous bolus injection of pranidipine (10 and 30 mu g/kg) significantly decreased mean circulatory filling pressure in a dose-dependent manner, as did nitroglycerin (30 and 100 mu g/kg). Nifedipine (30 and 100 mu g/kg), however, did not affect mean circulatory filling pressure. Amlodipine (1000 and 3000 mu g/kg) decreased mean circulatory filling pressure only at the higher dose. These results suggest that pranidipine has a greater venodilator effect than nifedipine and amlodipine.
引用
收藏
页码:201 / 204
页数:4
相关论文
共 50 条
  • [1] Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects
    K. Hashimoto
    T. Shirafuji
    H. Sekino
    O. Matsuoka
    H. Sekino
    O. Onnagawa
    T. Okamoto
    S. Kudo
    J. Azuma
    European Journal of Clinical Pharmacology, 1998, 54 : 753 - 760
  • [2] Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects
    Hashimoto, K
    Shirafuji, T
    Sekino, H
    Matsuoka, O
    Sekino, H
    Onnagawa, O
    Okamoto, T
    Kudo, S
    Azuma, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (9-10) : 753 - 760
  • [3] Differential properties of the optical-isomers of pranidipine, a 1,4-dihydropyridine calcium channel modulator
    Hirano, T
    Mori, T
    Kido, M
    Toide, K
    Ohura, M
    Fujiki, H
    Orito, K
    Yoshida, K
    Ikezono, K
    Sumida, T
    Nakayama, N
    Yabuuchi, Y
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (06) : 650 - 655
  • [4] THE 1,4-DIHYDROPYRIDINE RECEPTOR - A REGULATORY COMPONENT OF THE CA-2+ CHANNEL
    TRIGGLE, DJ
    JANIS, RA
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 : S949 - S955
  • [5] 1,4-DIHYDROPYRIDINE CA-2+ CHANNEL ANTAGONISTS AND ACTIVATORS - A COMPARISON OF BINDING CHARACTERISTICS WITH PHARMACOLOGY
    JANIS, RA
    TRIGGLE, DJ
    DRUG DEVELOPMENT RESEARCH, 1984, 4 (03) : 257 - 274
  • [6] COMPARISON OF LOCATION AND BINDING FOR THE POSITIVELY CHARGED 1,4-DIHYDROPYRIDINE CALCIUM-CHANNEL ANTAGONIST AMLODIPINE WITH UNCHARGED DRUGS OF THIS CLASS IN CARDIAC MEMBRANES
    MASON, RP
    CAMPBELL, SF
    WANG, SD
    HERBETTE, LG
    MOLECULAR PHARMACOLOGY, 1989, 36 (04) : 634 - 640
  • [7] MONOCLONAL-ANTIBODIES THAT COIMMUNOPRECIPITATE THE 1,4-DIHYDROPYRIDINE AND PHENYLALKYLAMINE RECEPTORS AND REVEAL THE CA2+ CHANNEL STRUCTURE
    VANDAELE, S
    FOSSET, M
    GALIZZI, JP
    LAZDUNSKI, M
    BIOCHEMISTRY, 1987, 26 (01) : 5 - 9
  • [8] AMLODIPINE, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST WITH A PARTICULARLY STRONG ANTIHYPERTENSIVE PROFILE
    FLECKENSTEIN, A
    FREY, M
    ZORN, J
    FLECKENSTEINGRUN, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (17): : I21 - I34
  • [9] PHARMACOLOGY AND THERAPEUTIC CONSIDERATIONS OF AMLODIPINE, A NEW 1,4-DIHYDROPYRIDINE CALCIUM-ANTAGONIST - INTRODUCTION
    SCHWARTZ, A
    VANZWIETEN, PA
    MATLIB, MA
    MILLARD, RW
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (17): : I1 - I2
  • [10] Pranidipine, a 1,4-dihydropyridine calcium channel blocker that enhances nitric oxide-induced vascular relaxation
    Mori, T
    Takase, H
    Toide, K
    Hirano, T
    Kambe, T
    Nakayama, N
    Schwartz, A
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (01): : 1 - 8